Cipla – The company earned 30% of its revenue from North America, ranking among the top 15 U.S. prescription drug providers with a focus on respiratory and oncology generics. Biocon – The U.S. was its ...
Healthcare stocks were trading in the negative zone, with the BSE Healthcare index falling 733.35 points or 1.82% at 39530.34 at 13:45 IST.
IST, the barometer index, the S&P BSE Sensex, slipped 465.15 points or 0.62% to 75,261.87. The Nifty 50 index declined 144.05 points or 0.63% to 22,769.10.
The Nifty Pharma index closed on a negative note on Thursday. Shares of Ipca Laboratories Ltd.(up 1.97 per cent), Gland ...
AM(IST)on Thursday in a weak market. Gland Pharma Ltd.(up 1.61 per cent), Cipla Ltd.(up 1.1 per cent), Lupin Ltd.(up 0.49 per ...
2d
Indian drugmakers prepare for US tariffs, emphasizing role in providing affordable medicines while navigating potential impacts and uncertainties.
Many pharma stocks ended lower on Wednesday amid fresh tariff concerns. Shares of Dr Reddy's dropped 2.63 per cent, Zydus Lifesciences went lower by 2.47 per cent, Aurobindo Pharma declined 2.41 per ...
U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...
Pharmaceutical stocks closed lower on Wednesday due to US President Trump's announcement of potential tariffs on auto, semiconductor, and pharmaceutical imports. Dr Reddy's, Zydus Lifesciences, ...
Portfolios of seasoned investors including Ashish Kacholia, Sunil Singhania, Ashish Dhawan, Dolly Khanna, Anil Goel and Akash Bhansali, often attracting interest of Dalal Street investors.
Motilal Oswal recommends buying UltraTech, Glenmark, and Zen Tech for strong growth. Explore their potential now!
KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1768 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback